Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Duration of Dual Antiplatelet Therapy After Drug Eluting Stent (DES) Implantation

NCT00822536 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT00822536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00822536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Duration of Dual Antiplatelet Therapy After Drug Eluting Stent (DES) Implantation
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
September 30, 2014
Enrollment
1,798 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, myocardial ischemia, stent thrombosis